Vertex Pharmaceuticals, Inc. (VRTX)
485.73
-1.70
(-0.35%)
USD |
NASDAQ |
Feb 25, 11:14
Vertex Pharmaceuticals Market Cap : 123.39B for Feb. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 20.19B |
| Gilead Sciences, Inc. | 183.16B |
| Eli Lilly & Co. | 982.32B |
| Merck & Co., Inc. | 305.72B |
| Pfizer Inc. | 152.95B |
Market Cap Related Metrics
| PE Ratio | 31.67 |
| PS Ratio | 10.38 |
| Price to Book Value | 6.611 |
| Price to Free Cash Flow | 39.24 |
| Price | 485.73 |
| Earnings Yield | 3.16% |
| Operating PE Ratio | 26.44 |
| Normalized PE Ratio | 28.96 |